Biogen: Citigroup raises target price to $255 from $215
BIIB•Citigroup raised its target price for Biogen to $255 from $215.
Related News
Arbe Robotics publishes update to financial calendar
ARBE•
aTyr Pharma's efzofitimod misses primary endpoint in Phase 3 pulmonary sarcoidosis trial
ATYR•
Tenable Holdings raises target price to $54 from $36
TENB•
Arrow Financial Q3 profit falls on merger costs
AROW•
374Water publishes updated October 2026 investor presentation
SCWO•